{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T15:52:45Z","timestamp":1772121165263,"version":"3.50.1"},"reference-count":19,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","license":[{"start":{"date-parts":[[2011,2,1]],"date-time":"2011-02-01T00:00:00Z","timestamp":1296518400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2011,2]]},"DOI":"10.1016\/j.juro.2010.09.087","type":"journal-article","created":{"date-parts":[[2010,12,18]],"date-time":"2010-12-18T04:14:58Z","timestamp":1292645698000},"page":"450-455","source":"Crossref","is-referenced-by-count":14,"title":["Frequency of Tumor Recurrence: A Strong Predictor of Stage Progression in Initially Diagnosed Nonmuscle Invasive Bladder Cancer"],"prefix":"10.1097","volume":"185","author":[{"given":"Nobuyuki","family":"Tanaka","sequence":"first","affiliation":[{"name":"Department of Urology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eiji","family":"Kikuchi","sequence":"additional","affiliation":[{"name":"Department of Urology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuhiro","family":"Matsumoto","sequence":"additional","affiliation":[{"name":"Department of Urology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Miyajima","sequence":"additional","affiliation":[{"name":"Department of Urology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ken","family":"Nakagawa","sequence":"additional","affiliation":[{"name":"Department of Urology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mototsugu","family":"Oya","sequence":"additional","affiliation":[{"name":"Department of Urology, Keio University School of Medicine, Tokyo, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"issue":"Suppl","key":"10.1016\/j.juro.2010.09.087_bib1","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.eursup.2007.05.003","article-title":"Prognostic factors in non-muscle-invasive bladder tumors: I. Clinical prognostic factors: a review of the experience of the EORTC Genito-Urinary Group II. Biologic Prognostic markers","volume":"6","author":"Kurth","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2010.09.087_bib2","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S0022-5347(17)38731-1","article-title":"Prognostic factors for recurrence and followup policies in the treatment of superficial bladder cancer: report from the British Medical Research Council Subgroup on Superficial Bladder Cancer (Urological Cancer Working Party)","volume":"142","author":"Parmar","year":"1989","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.09.087_bib3","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0022-5347(17)35397-1","article-title":"Predictability of recurrent and progressive disease in individual patients with primary superficial bladder cancer","volume":"150","author":"Kiemeney","year":"1993","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.09.087_bib4","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1046\/j.1464-410x.1998.00628.x","article-title":"The early clinical course of primary Ta and T1 bladder cancer: a proposed prognostic index","volume":"81","author":"Allard","year":"1998","journal-title":"Br J Urol"},{"key":"10.1016\/j.juro.2010.09.087_bib5","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0022-5347(05)67975-X","article-title":"Multivariate analysis of the prognostic factors of primary superficial bladder cancer","volume":"163","author":"Millan-Rodriguez","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.09.087_bib6","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0022-5347(05)67280-1","article-title":"Primary superficial bladder cancer risk groups according to progression, mortality and recurrence","volume":"164","author":"Millan-Rodriguez","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.09.087_bib7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1097\/01.ju.0000099825.98542.a8","article-title":"Initial tumor stage and grade as a predictive factor for recurrence in patients with stage T1 grade 3 bladder cancer","volume":"171","author":"Kwak","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.09.087_bib8","series-title":"European Association of Urology Guidelines on Ta T1 (Non-muscle invasive) Bladder Cancer (Updated March 2008)","author":"Babjuk","year":"2008"},{"key":"10.1016\/j.juro.2010.09.087_bib9","series-title":"Guidelines for the Management of Nonmuscle Invasive Bladder Cancer (stages Ta, T1, and Tis): Update (2007)","year":"2007"},{"key":"10.1016\/j.juro.2010.09.087_bib10","series-title":"NCCN Guidelines\u2122: Clinical Practice Guidelines in Oncology: Bladder Cancer Including Upper Tract Tumors and Urothelial Carcinoma of the Prostate","year":"2009"},{"key":"10.1016\/j.juro.2010.09.087_bib11","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1002\/(SICI)1097-0142(19991101)86:9<1818::AID-CNCR25>3.0.CO;2-0","article-title":"Intravesical chemotherapy for maximum prophylaxis of new early phase superficial bladder carcinoma treated by transurethral resection","volume":"86","author":"Hinotsu","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.juro.2010.09.087_bib12","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2010.09.087_bib13","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.juro.2008.05.013","article-title":"Multiplicity and history have a detrimental effect on survival of patients with T1G3 bladder tumors selected for conservative treatment","volume":"180","author":"Serretta","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.09.087_bib14","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.juro.2010.03.022","article-title":"Nonprimary pT1 nonmuscle invasive bladder cancer treated with bacillus Calmette-Guerin is associated with higher risk of progression compared to primary T1 tumors","volume":"184","author":"Alkhateeb","year":"2010","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.09.087_bib15","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/j.eururo.2007.10.006","article-title":"Prognostic factors in patients with non-muscle-invasive bladder cancer treated with bacillus Calmette-Gu\u00e9rin: multivariate analysis of data from four randomized CUETO trials","volume":"53","author":"Fernandez-Gomez","year":"2008","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2010.09.087_bib16","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.eururo.2009.08.024","article-title":"An updated critical analysis of the treatment strategy for newly diagnosed high-grade (previously T1G3) bladder cancer","volume":"57","author":"Kulkarni","year":"2010","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2010.09.087_bib17","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1097\/00005392-199707000-00017","article-title":"The treated natural history of high risk superficial bladder cancer: 15-year outcome","volume":"158","author":"Cookson","year":"1997","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2010.09.087_bib18","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.urology.2009.09.088","article-title":"Late recurrence and progression in non-muscle-invasive bladder cancers after 5-year tumor-free periods","volume":"75","author":"Matsumoto","year":"2010","journal-title":"Urology"},{"key":"10.1016\/j.juro.2010.09.087_bib19","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/0959-8049(95)00287-S","article-title":"Factors affecting recurrence and progression in superficial bladder tumors","volume":"31A","author":"Kurth","year":"1995","journal-title":"Eur J Cancer"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534710047208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534710047208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2010.09.087","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T21:44:48Z","timestamp":1651182288000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2010.09.087"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,2]]},"references-count":19,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,2]]}},"alternative-id":["10.1016\/j.juro.2010.09.087"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2010.09.087","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.9634956.10302054","asserted-by":"object"}]},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,2]]}}}